Aspira Women's Health appoints Marlene McLennan as interim CFO effective Dec 1, 2022

Aspira Women's Health Inc.

Marlene McLennan appointed interim CFO, effective December 1, 2022; prior CFO at Vestige Healthcare and other healthcare firms.
Annual base salary of $350,400; eligible for bonus up to 50% of base subject to board approval.
Stock option grants of 25,000 shares per 6-month term under 2019 Stock Incentive Plan.
Severance lump sum of $60,000 if terminated without cause or non-renewal, subject to performance criteria.
Employment agreement initial 6-month term, renewable up to 18 months total.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Marlene McLennan

interim Chief Financial Officer

AWHL · Aspira Women's Health Inc.

Effective: 2022-12-01
Filed: November 30, 2022, 6:59 PM ET

the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Marlene McLennan as the Company’s interim Chief Financial Officer, effective as of December 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marlene McLennan was appointed as interim Chief Financial Officer at Aspira Women's Health Inc..

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Marlene McLennan as the Company’s interim Chief Financial Officer, effective as of December 1, 2022.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000926617-22-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.